Literature DB >> 14989222

Bone scintigraphy: procedure guidelines for tumour imaging.

Emilio Bombardieri1, Cumali Aktolun, Richard P Baum, Angelika Bishof-Delaloye, John Buscombe, Jean François Chatal, Lorenzo Maffioli, Roy Moncayo, Luc Morteímans, Sven N Reske.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14989222     DOI： 10.1007/s00259-003-1347-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  42 in total

1.  Staging of breast cancer: new recommended standard procedure.

Authors:  Alberto Ravaioli; Giuseppe Pasini; Antonio Polselli; Maximilian Papi; Davide Tassinari; Valentina Arcangeli; Carlo Milandri; Dino Amadori; Matteo Bravi; Daniela Rossi; Pier Paolo Fattori; Enzo Pasquini; Ilaria Panzini
Journal:  Breast Cancer Res Treat       Date:  2002-03       Impact factor: 4.872

2.  Radionuclide three-phase whole-body bone imaging.

Authors:  David C Yang; Rita S Ratani; Pardeep K Mittal; Rufo S Chua; Surekha M Pate
Journal:  Clin Nucl Med       Date:  2002-06       Impact factor: 7.794

3.  Soft tissue uptake on 99mTc methylene diphosphonate bone scan imaging: pictorial review.

Authors:  J Kaye; Mike Hayward
Journal:  Australas Radiol       Date:  2002-03

Review 4.  Technical aspects of bone scintigraphy.

Authors:  M L Brown; M K O'Connor; J C Hung; R J Hayostek
Journal:  Radiol Clin North Am       Date:  1993-07       Impact factor: 2.303

5.  Prospective 153Sm-EDTMP therapy dosimetry by whole-body scintigraphy.

Authors:  P J Cameron; P F Klemp; A A Martindale; J H Turner
Journal:  Nucl Med Commun       Date:  1999-07       Impact factor: 1.690

Review 6.  Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions.

Authors:  G Savelli; L Maffioli; M Maccauro; E De Deckere; E Bombardieri
Journal:  Q J Nucl Med       Date:  2001-03

7.  Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53).

Authors: 
Journal:  Ann ICRP       Date:  1998

8.  Baseline staging tests in primary breast cancer: a practice guideline.

Authors:  R E Myers; M Johnston; K Pritchard; M Levine; T Oliver
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

9.  Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphate bone scan to detect bone metastases in patients with renal cell carcinomas - a preliminary report.

Authors:  H C Wu; R F Yen; Y Y Shen; C H Kao; C C Lin; C C Lee
Journal:  J Cancer Res Clin Oncol       Date:  2002-08-13       Impact factor: 4.553

Review 10.  Nuclear medicine studies in metabolic bone disease.

Authors:  Sharon F Hain; Ignac Fogelman
Journal:  Semin Musculoskelet Radiol       Date:  2002-12       Impact factor: 1.777
View more
  20 in total

1.  Pitfalls in bone density monitoring in prostate cancer during anti-resorptive treatment.

Authors:  Y-M Cheung; S K Ramchand; M Grossmann
Journal:  Osteoporos Int       Date:  2018-04-17       Impact factor: 4.507

2.  Guidelines for paediatric bone scanning with 99mTc-labelled radiopharmaceuticals and 18F-fluoride.

Authors:  Jan Stauss; Klaus Hahn; Mike Mann; Diego De Palma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

3.  Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.

Authors:  Andrei Iagaru; Erik Mittra; David W Dick; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2012-04       Impact factor: 3.488

Review 4.  Current role of bone scan with phosphonates in the follow-up of breast cancer.

Authors:  Lorenzo Maffioli; Luigia Florimonte; Luca Pagani; Ivana Butti; Isabel Roca
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-16       Impact factor: 9.236

5.  Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy.

Authors:  G Cascini; C Falcone; C Greco; B Bertucci; S Cipullo; O Tamburrini
Journal:  Radiol Med       Date:  2008-10-25       Impact factor: 3.469

6.  A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.

Authors:  Aseem Anand; Michael J Morris; Reza Kaboteh; Mariana Reza; Elin Trägårdh; Naofumi Matsunaga; Lars Edenbrandt; Anders Bjartell; Steven M Larson; David Minarik
Journal:  J Nucl Med       Date:  2016-07-21       Impact factor: 10.057

7.  Quality of planar whole-body bone scan interpretations--a nationwide survey.

Authors:  May Sadik; Madis Suurkula; Peter Höglund; Andreas Järund; Lars Edenbrandt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-29       Impact factor: 9.236

8.  Optimization of Ordered Subset Expectation Maximization Reconstruction for Reducing Urinary Bladder Artifacts in Single-photon Emission Computed Tomography Imaging.

Authors:  A M Katua; A O Ankrah; M Vorster; A van Gelder; M M Sathekge
Journal:  World J Nucl Med       Date:  2011-01

9.  Reduced acquisition times in whole body bone scintigraphy using a noise-reducing Pixon®-algorithm-a qualitative evaluation study.

Authors:  Oscar Ardenfors; Ulrika Svanholm; Hans Jacobsson; Patricia Sandqvist; Per Grybäck; Cathrine Jonsson
Journal:  EJNMMI Res       Date:  2015-09-16       Impact factor: 3.138

10.  Prevalence of exclusive lower extremity metastases at (18)F-NaF PET/CT.

Authors:  Monique Beraldo Ordones; Agnes Araujo Valadares; Paulo Schiavom Duarte; Heitor Naoki Sado; Marcos Santos Lima; Giovanna Carvalho; Marcelo Tatit Sapienza; Carlos Alberto Buchpiguel
Journal:  Radiol Bras       Date:  2015 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.